vs

Side-by-side financial comparison of MYRIAD GENETICS INC (MYGN) and PHOTRONICS INC (PLAB). Click either name above to swap in a different company.

PHOTRONICS INC is the larger business by last-quarter revenue ($210.4M vs $209.8M, roughly 1.0× MYRIAD GENETICS INC). On growth, MYRIAD GENETICS INC posted the faster year-over-year revenue change (-0.4% vs -5.5%). Over the past eight quarters, MYRIAD GENETICS INC's revenue compounded faster (1.9% CAGR vs -3.8%).

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.

MYGN vs PLAB — Head-to-Head

Bigger by revenue
PLAB
PLAB
1.0× larger
PLAB
$210.4M
$209.8M
MYGN
Growing faster (revenue YoY)
MYGN
MYGN
+5.1% gap
MYGN
-0.4%
-5.5%
PLAB
Faster 2-yr revenue CAGR
MYGN
MYGN
Annualised
MYGN
1.9%
-3.8%
PLAB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MYGN
MYGN
PLAB
PLAB
Revenue
$209.8M
$210.4M
Net Profit
$22.9M
Gross Margin
70.0%
33.7%
Operating Margin
-2.7%
22.9%
Net Margin
10.9%
Revenue YoY
-0.4%
-5.5%
Net Profit YoY
-32.4%
EPS (diluted)
$-0.09
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYGN
MYGN
PLAB
PLAB
Q4 25
$209.8M
Q3 25
$205.7M
$210.4M
Q2 25
$213.1M
$211.0M
Q1 25
$195.9M
$212.1M
Q4 24
$210.6M
$222.6M
Q3 24
$213.3M
$211.0M
Q2 24
$211.5M
$217.0M
Q1 24
$202.2M
$216.3M
Net Profit
MYGN
MYGN
PLAB
PLAB
Q4 25
Q3 25
$-27.4M
$22.9M
Q2 25
$-330.5M
$8.9M
Q1 25
$-100.0K
$42.9M
Q4 24
$33.9M
Q3 24
$-22.1M
$34.4M
Q2 24
$-36.7M
$36.3M
Q1 24
$-26.0M
$26.2M
Gross Margin
MYGN
MYGN
PLAB
PLAB
Q4 25
70.0%
Q3 25
69.9%
33.7%
Q2 25
71.2%
36.9%
Q1 25
68.5%
35.6%
Q4 24
71.7%
37.0%
Q3 24
70.2%
35.6%
Q2 24
69.6%
36.5%
Q1 24
68.1%
36.6%
Operating Margin
MYGN
MYGN
PLAB
PLAB
Q4 25
-2.7%
Q3 25
-11.3%
22.9%
Q2 25
-154.5%
26.4%
Q1 25
-14.8%
24.6%
Q4 24
-18.6%
25.1%
Q3 24
-9.4%
24.7%
Q2 24
-17.3%
25.8%
Q1 24
-13.8%
26.6%
Net Margin
MYGN
MYGN
PLAB
PLAB
Q4 25
Q3 25
-13.3%
10.9%
Q2 25
-155.1%
4.2%
Q1 25
-0.1%
20.2%
Q4 24
15.2%
Q3 24
-10.4%
16.3%
Q2 24
-17.4%
16.7%
Q1 24
-12.9%
12.1%
EPS (diluted)
MYGN
MYGN
PLAB
PLAB
Q4 25
$-0.09
Q3 25
$-0.29
$0.39
Q2 25
$-3.57
$0.15
Q1 25
$0.00
$0.68
Q4 24
$-0.47
$0.54
Q3 24
$-0.24
$0.55
Q2 24
$-0.41
$0.58
Q1 24
$-0.29
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYGN
MYGN
PLAB
PLAB
Cash + ST InvestmentsLiquidity on hand
$149.6M
$575.8M
Total DebtLower is stronger
$119.9M
$16.0K
Stockholders' EquityBook value
$368.0M
$1.1B
Total Assets
$706.6M
$1.8B
Debt / EquityLower = less leverage
0.33×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYGN
MYGN
PLAB
PLAB
Q4 25
$149.6M
Q3 25
$145.4M
$575.8M
Q2 25
$74.4M
$558.4M
Q1 25
$91.8M
$642.2M
Q4 24
$102.4M
$640.7M
Q3 24
$99.9M
$606.4M
Q2 24
$97.3M
$559.9M
Q1 24
$104.3M
$521.5M
Total Debt
MYGN
MYGN
PLAB
PLAB
Q4 25
$119.9M
Q3 25
$119.5M
$16.0K
Q2 25
$19.0K
Q1 25
$21.0K
Q4 24
$25.0K
Q3 24
$28.0K
Q2 24
$2.5M
Q1 24
$2.7M
Stockholders' Equity
MYGN
MYGN
PLAB
PLAB
Q4 25
$368.0M
Q3 25
$372.8M
$1.1B
Q2 25
$388.1M
$1.1B
Q1 25
$704.9M
$1.1B
Q4 24
$701.1M
$1.1B
Q3 24
$731.7M
$1.1B
Q2 24
$740.5M
$1.0B
Q1 24
$760.0M
$1.0B
Total Assets
MYGN
MYGN
PLAB
PLAB
Q4 25
$706.6M
Q3 25
$728.1M
$1.8B
Q2 25
$677.3M
$1.7B
Q1 25
$1.0B
$1.7B
Q4 24
$1.0B
$1.7B
Q3 24
$1.1B
$1.6B
Q2 24
$1.1B
$1.6B
Q1 24
$1.1B
$1.6B
Debt / Equity
MYGN
MYGN
PLAB
PLAB
Q4 25
0.33×
Q3 25
0.32×
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYGN
MYGN
PLAB
PLAB
Operating Cash FlowLast quarter
$10.6M
$50.1M
Free Cash FlowOCF − Capex
$25.2M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
2.19×
TTM Free Cash FlowTrailing 4 quarters
$64.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYGN
MYGN
PLAB
PLAB
Q4 25
$10.6M
Q3 25
$21.1M
$50.1M
Q2 25
$-13.6M
$31.5M
Q1 25
$-16.3M
$78.5M
Q4 24
$6.6M
$68.4M
Q3 24
$700.0K
$75.1M
Q2 24
$2.6M
$76.5M
Q1 24
$-18.6M
$41.5M
Free Cash Flow
MYGN
MYGN
PLAB
PLAB
Q4 25
Q3 25
$25.2M
Q2 25
$-29.1M
Q1 25
$43.3M
Q4 24
$25.2M
Q3 24
$50.7M
Q2 24
$56.5M
Q1 24
$-1.8M
FCF Margin
MYGN
MYGN
PLAB
PLAB
Q4 25
Q3 25
12.0%
Q2 25
-13.8%
Q1 25
20.4%
Q4 24
11.3%
Q3 24
24.0%
Q2 24
26.0%
Q1 24
-0.8%
Capex Intensity
MYGN
MYGN
PLAB
PLAB
Q4 25
Q3 25
11.8%
Q2 25
28.7%
Q1 25
16.6%
Q4 24
19.4%
Q3 24
11.6%
Q2 24
9.2%
Q1 24
20.0%
Cash Conversion
MYGN
MYGN
PLAB
PLAB
Q4 25
Q3 25
2.19×
Q2 25
3.55×
Q1 25
1.83×
Q4 24
2.02×
Q3 24
2.18×
Q2 24
2.11×
Q1 24
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MYGN
MYGN

Segment breakdown not available.

PLAB
PLAB

High End Integrated Circuits$53.6M25%
High End Flat Panel Displays$53.5M25%
KR$43.7M21%
Other$42.1M20%
Mainstream Flat Panel Displays$9.1M4%
Transferred At Point In Time$8.4M4%

Related Comparisons